DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-28.95%
US · US
CCI.US latest organized financial period shows revenue declined -35.08% YoY and net income grew +111% YoY. Current price is about 86.06 USD, while the model base case is about 45.72 USD; the current price sits +88.2% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:26
Hover each model row to inspect formulas and inputs.
+88.23%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-28.95%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
+167%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly -1.3% annualized FCF growth.
Estimates earnings power value without assuming growth.
+88.23%
Updated: 2026/04/29 15:26
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Asset impairment | Impairment | -9M USD | Medium |
| 2024/12/31 | Asset impairment | Impairment | -126M USD | Medium |
| 2024/12/31 | Restructuring charges | Restructuring | -141M USD | Medium |
| 2023/12/31 | Asset impairment | Impairment | -59M USD | Medium |
| 2023/12/31 | Restructuring charges | Restructuring | -192M USD | Medium |
| 2022/12/31 | Asset impairment | Impairment | -81M USD | Medium |
| 2021/12/31 | Asset impairment | Impairment | -50M USD | Medium |
| 2021/12/31 | Discontinued operations | Discontinued operations | -186M USD | High |
| 2020/12/31 | Asset impairment | Impairment | -175M USD | Medium |
| 2025/09/30 | Asset impairment | Impairment | -8M USD | Medium |
| 2025/06/30 | Asset impairment | Impairment | -5M USD | Medium |
| 2025/03/31 | Asset impairment | Impairment | -2M USD | Medium |
| 2024/09/30 | Asset impairment | Impairment | -40M USD | Medium |
| 2024/09/30 | Restructuring charges | Restructuring | -203M USD | Medium |
| 2024/06/30 | Asset impairment | Impairment | -18M USD | Medium |
| 2024/06/30 | Restructuring charges | Restructuring | -119M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 4B USD | 444M USD | 453M USD | 3B USD | 1.01 | 1.03 |
| 2024/12/31 | Annual | 7B USD | -4B USD | -4B USD | 3B USD | -8.98 | -8.37 |
| 2023/12/31 | Annual | 7B USD | 2B USD | 2B USD | 3B USD | 3.46 | 4.04 |
| 2022/12/31 | Annual | 7B USD | 2B USD | 2B USD | 3B USD | 3.86 | 4.05 |
| 2021/12/31 | Annual | 6B USD | 1B USD | 1B USD | 3B USD | 2.53 | 3.07 |
Total revenue recognized in each fiscal year.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.